Loading…
Loading…
pharmaceuticals
Ori Biotech is a cell and gene therapy manufacturing technology company founded in 2015 by Dr. Farlan Veraitch and Prof. Chris Mason. With locations in London, Philadelphia, and New Jersey, Ori develops proprietary manufacturing platforms aimed at automating and standardizing the production of cell and gene therapies. Their mission is to enhance patient access to these therapies by addressing manufacturing challenges such as high costs and variability. The company's main offering is the IRO® platform, which integrates automation, data analytics, and a benchtop cell processing system to streamline the manufacturing process. This platform supports various therapy types, initially focusing on cell therapies like CAR-T. Ori also launched the Lightspeed Early Access Program (LEAP) in 2022, providing select partners with pre-launch access to their technology. Ori Biotech has formed partnerships with organizations like Achilles Therapeutics and Hitachi Chemical, targeting therapy developers and contract manufacturers as key customer segments.
Ori Biotech is a cell and gene therapy manufacturing technology company founded in 2015 by Dr. Farlan Veraitch and Prof. Chris Mason. With locations in London, Philadelphia, and New Jersey, Ori develops proprietary manufacturing platforms aimed at automating and standardizing the production of cell and gene therapies. Their mission is to enhance patient access to these therapies by addressing manufacturing challenges such as high costs and variability. The company's main offering is the IRO® platform, which integrates automation, data analytics, and a benchtop cell processing system to streamline the manufacturing process. This platform supports various therapy types, initially focusing on cell therapies like CAR-T. Ori also launched the Lightspeed Early Access Program (LEAP) in 2022, providing select partners with pre-launch access to their technology. Ori Biotech has formed partnerships with organizations like Achilles Therapeutics and Hitachi Chemical, targeting therapy developers and contract manufacturers as key customer segments.
Ori Biotech has been mentioned across 4 podcasts.
Represent this company? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
